More research is needed.
For decades, patients, families, clinicians, and researchers have heard the same answer when treatments remain uncertain:
More research is needed.
The challenge is not simply a lack of research. Clinical research is often fragmented across institutions, investigators, populations, regulatory systems, manufacturing and supply pathways, pharmacies, funding sources, and patient access.
IAMB TbT Groups is working to help connect those pieces.
For design, make the first “More research is needed.” the big dark-green heading, and make the repeated More research is needed. in the middle bold/gold or dark green so it lands visually.
One Infrastructure. Connected Research.
IAMB TbT Groups is developing a connected clinical research ecosystem designed to bring together the people, systems, and safeguards needed to move promising therapies from research toward responsible access.
Protocol-driven research built around Good Clinical Practice and meaningful outcomes.
Regulatory readiness incorporating GCP, FDA, DEA, IRB, and applicable clinical requirements.
Supporting the responsible evaluation of traditional, emerging, and investigational therapies.
Developing research-pharmacy and medication-access pathways centered on safety, accountability, and clinical oversight.
Protecting participants through education, monitoring, responsible access, and evidence-based practice.
The Future of Medicine Will Be Collaborative.
IAMB TbT Groups welcomes collaboration with researchers, healthcare professionals, research institutions, life-science organizations, pharmacists, qualified manufacturers, funders, and strategic partners working toward responsible clinical research and therapeutic access.